Distribution of common genetic subgroups in childhood acute lymphoblastic leukemia in four developing countries

Cancer Genetics and Cytogenetics

Volumn 200, Issue 2, 2010, Pages 149-153

  Siddiqui, Rubina ^a   Nancy, Nirmala ^b   Naing, Win P ^c   Ali, Sarah ^d   Dar, Lalit ^e   Khan, Baldip K ^f   Padua, Rose A ^g   Carr, Robert ^h  

^a NATIONAL INSTITUTE FOR BIOTECHNOLOGY AND GENETIC ENGINEERING NIBGE   (Pakistan)

^b CANCER INSTITUTE WIA   (India)

^c National Blood Research Centre   (Myanmar)

^d UNIVERSITY OF KHARTOUM   (Sudan)

^e ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^f INTERNATIONAL ATOMIC ENERGY AGENCY   (Austria)

^g UNIVERSITÉ PARIS DIDEROT   (France)

^h KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BCR ABL PROTEIN; COMPLEMENTARY DNA; MIXED LINEAGE LEUKEMIA PROTEIN; TRANSCRIPTION FACTOR ETV6; TRANSCRIPTION FACTOR PBX1; TRANSCRIPTION FACTOR RUNX1;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BONE MARROW BIOPSY; CANCER CHEMOTHERAPY; CHILD; CYTOCHEMISTRY; DEVELOPING COUNTRY; FUSION GENE; GENE AMPLIFICATION; GENE IDENTIFICATION; GENETIC VARIABILITY; HUMAN; IMMUNOPHENOTYPING; INDIA; LABORATORY DIAGNOSIS; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MOLECULAR EPIDEMIOLOGY; MYANMAR; PAKISTAN; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUDAN;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; FUSION PROTEINS, BCR-ABL; HUMANS; INDIA; INFANT; INFANT, NEWBORN; MALE; MYANMAR; MYELOID-LYMPHOID LEUKEMIA PROTEIN; ONCOGENE PROTEINS, FUSION; PAKISTAN; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; SUDAN;

EID: 77953755153     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2010.04.010     Document Type: Article

References (24)

1. Pui C.H., Schrappe M., Masera G., Nachman J., Gadner H., Eden O.B., et al. Meeting Report, Ponte di Legno Working Group. Appendix A. Position paper/statement by members of the Ponte di Legno group on the right of children with leukemia to have full access to essential treatment for acute lymphoblastic leukaemia. Leukemia 2004, 18:1043-1053.
2. Maloney K., McGavran L., Murphy J., Odom L., Stork L., Wei Q., et al. TEL-AML1 fusion identifies a subset of children with standard risk acute lymphoblastic leukemia who have an excellent prognosis when treated with therapy that includes a single delayed intensification. Leukemia 1999, 13:1708-1712.
3. Borkhardt A., Cazzaniga G., Viehmann S., Valsecchi M.G., Ludwig W.D., Burci L., et al. Incidence and clinical relavance of TEL/AML1 fusion genes in children with acute lymphoblastic leukaemia enrolled in the German and Italian multicenter therapy trials. Blood 1997, 90:571-577.
4. Kanerva J., Saarinen-Pihkala M.D., Niini T., Riikonen P., Möttönen M., Mäkipernaa A., et al. Favourable outcome in 20 year follow-up of children with very-low-risk ALL and minimal standard therapy, with special reference to TEL-AML1 fusion. Pediatr Blood Cancer 2004, 42:30-35.
5. Hann I., Vora A., Harrison G., Harrison C., Eden O., Hill F., et al. Determinants of outcome after intensified therapy of childhood lymphoblastic leukaemia: results from Medical Research Council United Kingdom acute lymphoblastic leukaemia XI protocol. Br J Haematol 2001, 113:103-114.
6. Moorman A.V., Richards S.M., Robinson H.R., Strefford J.C., Gibson B.E., Kinsey S.E., et al. Prognosis of children with acute lymphoblastic leukemia (ALL) and intrachromosomal amplification of chromosome 21 (iAMP21). Blood 2007, 109:2327-2330.
7. Magalhaes I.Q., Pombo-de-Oliveira M.S., Bennett C.A., Silla L., Daudt L., Fernandes M.S., et al. TEL-AML1 fusion gene frequency in paediatric acute lymphoblastic leukaemia in Brazil. Br J Haematol 2000, 111:204-207.
8. Pallisgaard N., Hokland P., Riishøj D.C., Pedersen B., Jørgensen P. Multiplex reverse transcription-polymerase chain reaction for simultaneous screening of 29 translocations and chromosomal aberrations in acute leukemia. Blood 1998, 92:574-588.
9. van Dongen J.J., Macintyre E.A., Gabert J.A., Delabesse E., Rossi V., Saglio G., et al. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia. Leukemia 1999, 13:1901-1928.
10. Castaigne S., Balitrand N., de Thé H., Dejean A., Degos L., Chomienne C. A PML/retinoic acid receptor alpha fusion transcript is constantly detected by RNA-based polymerase chain reaction in acute promyelocytic leukemia. Blood 1992, 79:3110-3115.
11. Crist W.M., Carroll A.J., Shuster J.J., Behm F.G., Whitehead M., Vietti T.J., et al. Poor prognosis of children with pre-B acute lymphoblastic leukaemia is associated with the t(1;19) (q23;p13): a Pediatric Oncology Group study. Blood 1990, 76:117-122.
12. Siraj A.K., Kamat S., Gutierrez M.I., Banavali S., Timpson G., Sazawal S., et al. Frequencies of the major subgroups of precursor B-cell acute lymphoblastic leukaemia in Indian children differ from the West. Leukemia 2003, 17:1192-1193.
13. Sazawal S., Bhatia K., Gutierrez M.I., Saxena R., Arya L.S., Bhargava M. Paucity of TEL-AML1 translocation, by multiplex RT-PCR, in B-lineage acute lymphoblastic leukaemia (ALL) in indian patients. Am J Hematol 2004, 76:80-82.
14. Hill A., Short M.A., Varghese C., Kusumakumary P., Kumari P., Morgan G.J. The t(12:21) is underrepresented in childhood B-lineage acute lymphoblastic leukaemia in Kerala, Southern India. Haematologica 2005, 90:414-416.
15. Settin A., Al Haggar M., Al Dosoky T., Al Baz R., Abdelrazik N., Fouda M., et al. Prognostic cytogenetic markers in childhood acute lymphoblastic leukemia: cases from Mansoura Egypt. Hematology 2007, 12:103-111.
16. Gmidène A., Sennana H., Elghezal H., Ziraoui S., Youssef Y.B., Elloumi M., et al. Cytogenetic analysis of 298 newly diagnosed cases of acute lymphoblastic leukaemia in Tunisia. Hematol Oncol 2008, 26:91-97.
17. Ariffin H., Chen S.P., Kwok C.S., Quah T.C., Lin H.P., Yeoh A.E. Ethnic differences in the frequency of subtypes of childhood acute lymphoblastic leukemis: results of the Malaysia-Singapore leukemia study group. J Pediatr Hematol Oncol 2007, 29:27-31.
18. Gao Y.J., Zhu X.H., Yang Y., Wu Y., Lu F.J., Zhai X.W., et al. Prevalence of ETV6-RUNX1 fusion gene in children with acute lymphoblastic leukemia in China. Cancer Genet Cytogenet 2007, 178:57-60.
19. Zen P.R., Lima M.C., Coser V.M., Silla L., Daudt L., Fernandes M.S., et al. Prevalence of TEL/AML1 fusion gene in Brazilian pediatric patients with acute lymphoblastic leukaemia. Cancer Genet Cytogenet 2004, 151:68-72.
20. Jiménez-Morales S., Miranda-Peralta E., Saldaña-Alvarez Y., Perez-Vera P., Paredes-Aguilera R., Rivera-Luna R., et al. BCR-ABL, ETV6-RUNX1 and E2A-PBX1: prevalence of the most common acute lymphoblastic leukemia fusion genes in Mexican patients. Leuk Res 2008, 32:1518-1522.
21. Greaves M. Infection, immune responses and the aetiology of childhood leukaemia. Nat Rev Cancer 2006, 6:193-203.
22. Greaves M., Wielmels J. Origins of chromosome translocations in childhood leukaemia. Nat Rev Cancer 2003, 3:1-11.
23. Gilham C., Peto J., Simpson J., Roman E., Eden O.B., Greaves M.F., et al. Day care in infancy and risk of childhood acute lymphoblastic leukaemia: findings from a UK case-control study. BMJ 2005, 330:1294-1299. for the UKCCS Investigators.
24. Urayama K.Y., Buffler P.A., Gallagher E.R., Ayoob J.M., Ma X. A meta-analysis of association between day-care attendance and childhood acute lymphoblastic leukaemia. Int J Epidemiol 2010, (in press).